VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PACB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PACBPacific Biosciences of California, Inc.
$1.66$516M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPACBPrice History

PACB logoPacific Biosciences of California, Inc. (PACB) Stock Price History

Historical prices from 2010 to 2026

$1.66-0.02  (-1.19%)close Jul 6
Returns
1M
+20.3%
3M
+16.9%
YTD
-9.8%
1Y
+12.9%
3Y
-48.5%
5Y
-45.0%
ATH$53.69Feb 2021-96.9%
ATL$0.85May 2025pre-split
Avg Vol (50D)5.8M/ day
52-Week Range$1.09 — $2.73
LowCurrent: $1.66High

Loading 10-year price history...

PACB Historical Performance

1 YearTotal Return
+12.9%
Price: +12.9%
3 YearsTotal Return
-86.4%
CAGR: -48.5%
Price: -86.4%
5 YearsTotal Return
-95.0%
CAGR: -45.0%
Price: -95.0%
YTD
-9.8%

PACB Annual Returns

Year-by-year price performance · 2010–2026

Best+402.7%2020
Worst-82.8%2011
Up years7/17
2010-3.2%
2011-82.8%
2012-42.4%
2013+182.7%
2014+54.6%
2015+68.1%
2016-71.2%
2017-39.4%
2018+165.2%
2019-30.5%
2020+402.7%
2021-22.4%
2022-60.9%
2023+23.6%
2024-80.9%
2025+3.9%
2026-8.7%
2010 annual price return
-3.2%
2011 annual price return
-82.8%
2012 annual price return
-42.4%
2013 annual price return
+182.7%
2014 annual price return
+54.6%
2015 annual price return
+68.1%
2016 annual price return
-71.2%
2017 annual price return
-39.4%
2018 annual price return
+165.2%
2019 annual price return
-30.5%
2020 annual price return
+402.7%
2021 annual price return
-22.4%
2022 annual price return
-60.9%
2023 annual price return
+23.6%
2024 annual price return
-80.9%
2025 annual price return
+3.9%
2026 annual price return
-8.7%
LessMore
Alpha vs S&P 500
1Y-0.8%
3Y-72.2%
5Y-58.5%

Price returns only.

Download Historical Data

3,945 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PACB Stock Price Trajectory (2010–2026)

As of July 7, 2026, Pacific Biosciences of California, Inc. (PACB) trades at $1.66, representing a +12.9% return over the past year. The stock has delivered a -95.0% total return over five years (-45.0% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $53.69 on February 11, 2021. From this peak, PACB has corrected -96.9%, currently trading 2% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ILMN (+100.0% 1Y), BFLY (+337.8% 1Y), and CDNA (+57.5% 1Y), PACB has underperformed the peer group average. Compare PACB vs ILMN →

PACB Historical Price Data · from 2010

Rows 1–50 of 3,945
Date Open High Low Close Volume Change %
2026-07-061.641.721.611.663.82M-1.19%
2026-07-021.751.831.671.685.27M-3.45%
2026-07-011.671.801.661.745.00M+3.57%
2026-06-301.731.751.601.686.88M-2.89%
2026-06-291.681.781.661.738.29M+4.85%
2026-06-261.581.711.561.650+3.13%
2026-06-251.441.681.441.6010.56M+11.11%
2026-06-241.311.481.311.446.11M+9.92%
2026-06-231.311.371.291.314.87M-0.76%
2026-06-221.391.411.321.324.48M-5.71%
2026-06-181.371.431.361.404.18M+4.48%
2026-06-171.341.451.341.344.78M-0.74%
2026-06-161.331.391.321.353.67M+2.27%
2026-06-151.351.391.301.325.26M+0.76%
2026-06-121.361.391.301.314.95M-2.96%
2026-06-111.351.371.311.355.00M-1.46%
2026-06-101.361.441.361.374.93M0.00%
2026-06-091.401.441.311.373.76M-0.72%
2026-06-081.471.491.351.384.21M-4.83%
2026-06-051.581.591.401.456.47M-11.04%
2026-06-041.611.771.581.637.84M+3.16%
2026-06-031.571.591.491.586.79M0.00%
2026-06-021.561.631.521.587.62M0.00%
2026-06-011.461.621.441.588.45M+6.04%
2026-05-291.471.531.431.496.99M+1.36%
2026-05-281.291.481.291.479.10M+13.95%
2026-05-271.261.311.251.293.37M+2.38%
2026-05-261.241.281.191.266.06M+3.28%
2026-05-221.251.281.211.224.55M-2.40%
2026-05-211.181.271.171.253.93M+5.04%
2026-05-201.151.201.141.193.62M+3.48%
2026-05-191.161.191.121.155.16M0.00%
2026-05-181.141.201.091.157.86M+2.68%
2026-05-151.201.211.121.129.28M-7.44%
2026-05-141.271.301.201.219.54M-4.72%
2026-05-131.281.321.251.274.97M-0.78%
2026-05-121.341.361.281.286.76M-5.54%
2026-05-111.391.451.351.354.47M-3.90%
2026-05-081.521.521.351.419.75M-14.55%
2026-05-071.701.761.631.656.06M-3.51%
2026-05-061.601.731.581.717.06M+8.23%
2026-05-051.551.581.501.585.77M+1.94%
2026-05-041.571.621.531.553.60M-3.13%
2026-05-011.591.621.531.604.97M+0.63%
2026-04-301.481.601.481.594.96M+8.16%
2026-04-291.551.561.421.475.88M-6.96%
2026-04-281.561.581.531.583.97M-0.63%
2026-04-271.541.681.531.597.08M+1.92%
2026-04-241.551.631.511.5611.02M-1.27%
2026-04-231.681.691.551.589.65M-7.60%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PACB — Frequently Asked Questions

Quick answers to the most common questions about buying PACB stock.

How has PACB stock performed recently?

PACB returned +12.9% over the past year, beating its 5-year annualized CAGR of -45.0%. The stock trades below its 200-day moving average, confirming the uptrend.

What is PACB's all-time high price?

Pacific Biosciences of California, Inc. reached $53.69 on 2021-02-11. The 52-week high is $2.73. Current 1-year return of +12.9% places the stock closer to historical peaks.

Where can I download PACB historical price data?

This page provides PACB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2010-2026, downloadable in CSV format.

494 data points · sampled from 3,945